Articles
Heating block systems support synthesis research
Monash University's School of Chemistry has invested in a range of Asynt DrySyn Multi heating block systems to support its groundbreaking research in photovoltaics, water splitting and nanoimaging. [ + ]
Clinuvel gets orphan status for Scenesse in HHD
Clinuvel (ASX:CUV) has received EMA orphan drug designation for Scenesse in Hailey-Hailey Disease, and has revealed it expects the agency to complete its review of the product in EPP by October. [ + ]
Heavy mouse enables hard-hitting research
Scientists from the University of Cambridge have created the world's first animal enriched with heavy but non-radioactive isotopes. The 'heavy' mouse has enabled the scientists to capture in unprecedented detail the molecular structure of natural tissue by reading the magnetism inherent in the isotopes. [ + ]
Single-cell analysis inspired by microchips
US and Korean researchers have developed a device, similar to a random-access memory (RAM) chip, which moves cells rather than electrons. The device could be scaled up to sort and store hundreds of thousands of individual living cells in a matter of minutes. [ + ]
Phylogica hit with two market setbacks
Phylogica's (ASX:PYC) research partner Janssen Pharmaceuticals has elected not to license the outcome of their collaboration and a Phylogica licensee has filed for bankruptcy. [ + ]
A powerful body scanner for an advanced imaging facility
The University of Queensland's Centre for Advanced Imaging has acquired an $11 million 7 T MRI scanner, said to be the most powerful body scanner in the Southern Hemisphere. [ + ]
Virax names new managing director
Virax Holdings (ASX:VHL) has announced that former Arana Therapeutics executive Dr Rob Crombie will join the company as managing director in mid-June. [ + ]
Australia's scientists react to the Budget
The 2014-15 Budget will affect several areas of science, provoking comments from experts involved in the industry. [ + ]
CSL opens recombinant therapy plant in Vic
CSL (ASX:CSL) has opened a biotechnology manufacturing plant in Melbourne as part of a $257m expansion of its Broadmeadows facilities. [ + ]
GI Dynamics expands reach of EndoBarrier in AU
GI Dynamics (ASX:GID) has revealed that two more Australian sites are offering its obesity and diabetes device therapy EndoBarrier and has published research into the treatment's mechanism of action. [ + ]
Building bone marrow-on-a-chip
Researchers from the Wyss Institute have created a new organ-on-a-chip - a microfluidic device that mimics the physiology of a living organism. The device reproduces the structure, functions and cellular make-up of bone marrow. [ + ]
Prima gets FDA fast-track status for CVac
Shares in Prima BioMed grew 30% after the company revealed it has won fast-track designation in the US for CVac in platinum-sensitive epithelial ovarian cancer in second remission. [ + ]
Scientists create a superheavy element
An international research team has created and observed several atoms of the superheavy element with atomic number 117. The measured properties of the atoms strengthen the case for official recognition of 117 as a new element. [ + ]
Novogen forms child cancer R&D partnership
Novogen (ASX:NRT) has entered separate research collaborations aimed at adapting its super-benzopyran drugs to treat solid childhood cancers and neurodegenerative diseases. [ + ]
Fibrotech bought by Shire for at least $81m
Melbourne-based biopharma Fibrotech has agreed to be bought out by Shire for an initial US$75 million ($80.9 million). The deal will also involve development and regulatory milestone payments. [ + ]
